Novel Equations for Estimating Lean Body Mass in Patients With Chronic Kidney Disease
NCT ID: NCT04074278
Last Updated: 2019-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2013-03-01
2015-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: We developed and tested a reliable equations for estimation of LBM in daily clinical practice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Exercise and Protein Supplementation on Muscle Function in Patients With Hemodialysis
NCT04927208
The Optimal Protein Intake to Enhance Muscle Mass in Elderly Patients With Pre-dialysis Chronic Kidney Disease
NCT07102667
The Effects of Obesity and Protein Intake on the Kidney
NCT00244790
Estimation of Muscle Mass in Older Adults Using Deuterated Creatine
NCT02062086
Protein and Exercise Training in Chronic KIDNEY Disease
NCT05482243
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
development groups
The development groups included 150 patients derived from outpatients in Peking University First Hospital, between March 1st, 2014 and November 26th 2014.
No interventions assigned to this group
validation groups
The validation groups included 150 patients derived from outpatients in Peking University First Hospital, between November 27th 2014 and December 1st, 2015.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinical stable
* a willingness to be examined with all measurements being taken simultaneously.
Exclusion Criteria
* severe edema within one month prior to the study
* chronic infections, connective tissue disease, hyper- or hypothyroidism, amputations or pregnancy,
* taking immunosuppressive agents and anti-inflammatory medication chronically
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University First Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong Jie
Clinical Professor of Institute of Nephrology, Division of Renal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Renal Division and Institute of Nephrology, Peking University First Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LBM eqations
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.